Value Bridge — PARKVIEW MEDICAL CENTER
Current $21M → Target $33M (+$11.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$21.3M
Current EBITDA
$32.9M
Target EBITDA
+$11.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.6M
Payer Mix Optimization
$6.3M
Cost to Collect Reduction
$2.1M
Clean Claim Improvement
$1.6M
Volume & Rate Growth
$10.5M
What This Means
The 7-lever model projects a 54% EBITDA uplift from $21M to $33M. The highest-impact lever is Volume & Rate Growth at $4.2M probability-weighted.
IC talking point: "We see $12M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $127M in equity value creation."